Synthetic analogue of insulin-like growth factor 1 (IGF-1) studied in cellular growth and signalling research Engineered with an extended amino acid sequence and reduced binding affinity to IGF binding proteins compared to native IGF-1 Investigated in laboratory models involving cell proliferation, differentiation, and metabolic signalling pathways Supplied as high purity lyophilised peptide powder Form: Lyophilised peptide powder Strength: 1mg Purity: 99% Verification: HPLC and Mass Spectrometry
This receptor selectivity profile distinguished Ipamorelin from earlier GHRPs and established it as a research reference compound for GHS-R1a pharmacology
The frequency of infusions can vary based on individual needs, ranging from an initial boost of weekly infusions to a maintenance schedule of monthly sessions
The peptide binds GHRH receptors on anterior pituitary somatotroph cells, activates adenylyl cyclase to increase intracellular cAMP, enhances transcription of the GH gene, and stimulates exocytosis of stored GH from secretory granules
Dose is the size of the knock on the door
How does this peptide blend work
